Advertisement

Digestive Diseases and Sciences

, Volume 59, Issue 7, pp 1645–1646 | Cite as

Prevalence and Relevance of Nonalcoholic Fatty Liver Disease in Patients with Primary Sclerosing Cholangitis

  • Iliana Doycheva
  • Kristen Cox
  • Abdul Haseeb
  • Douglas G. Adler
Correspondence

Keywords

Inflammatory Bowel Disease NASH Cholangiocarcinoma Primary Sclerosing Cholangitis Inflammatory Bowel Disease Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Bellentani S, Scaglioni F, Marino M, Bedogni G. Epidemiology of non-alcoholic fatty liver disease. Dig Dis. 2010;28:155–161.PubMedCrossRefGoogle Scholar
  2. 2.
    Browning JD. Statins and hepatic steatosis: perspectives from the Dallas Heart Study. Hepatology. 2006;44:466–471.PubMedCrossRefGoogle Scholar
  3. 3.
    Sourianarayanane A, Garg G, Smith TH, et al. Risk factors of non-alcoholic liver disease in patients with inflammatory bowel disease. J Crohns Colitis. 2013;7:e279–e285.PubMedCrossRefGoogle Scholar
  4. 4.
    Reddy SK, Hyder O, Marsh JW, et al. Prevalence of nonalcoholic steatohepatitis among patients with resectable intrahepatic cholangiocarcinoma. J Gastrointest Surg. 2013;17:748–755.PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Iliana Doycheva
    • 1
  • Kristen Cox
    • 1
  • Abdul Haseeb
    • 2
  • Douglas G. Adler
    • 1
  1. 1.Division of Gastroenterology and HepatologyUniversity of Utah School of MedicineSalt Lake CityUSA
  2. 2.Department of Internal MedicineUniversity of Utah School of MedicineSalt Lake CityUSA

Personalised recommendations